Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
3(50%)
Results Posted
50%(1 trials)

Phase Distribution

Ph not_applicable
3
50%
Ph phase_1
1
17%
Ph early_phase_1
1
17%

Phase Distribution

2

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Early Phase 1First-in-human
1(20.0%)
Phase 1Safety & dosage
1(20.0%)
N/ANon-phased studies
3(60.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

6

all time

Status Distribution
Active(4)
Completed(2)

Detailed Status

Active, not recruiting2
Completed2
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
3
Success Rate
100.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (20.0%)
Phase 11 (20.0%)
N/A3 (60.0%)

Trials by Status

not_yet_recruiting117%
active_not_recruiting233%
recruiting117%
completed233%

Recent Activity

Clinical Trials (6)

Drug Details

Intervention Type
DEVICE
Total Trials
6